NDC 0781-4054

Lansoprazole, Amoxicillin and Clarithromycin

Lansoprazole, Amoxicillin And Clarithromycin

Lansoprazole, Amoxicillin and Clarithromycin is a Kit in the Human Prescription Drug category. It is labeled and distributed by Sandoz Inc. The primary component is .

Product ID0781-4054_ab44b2c9-3e8b-4b4e-a04f-574825415869
NDC0781-4054
Product TypeHuman Prescription Drug
Proprietary NameLansoprazole, Amoxicillin and Clarithromycin
Generic NameLansoprazole, Amoxicillin And Clarithromycin
Dosage FormKit
Marketing Start Date2014-03-04
Marketing CategoryANDA / ANDA
Application NumberANDA202588
Labeler NameSandoz Inc
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0781-4054-42

14 BLISTER PACK in 1 CARTON (0781-4054-42) > 1 KIT in 1 BLISTER PACK (0781-4054-32)
Marketing Start Date2014-03-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0781-4054-42 [00781405442]

Lansoprazole, Amoxicillin and Clarithromycin KIT
Marketing CategoryANDA
Application NumberANDA202588
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-03-04

NDC 0781-4054-32 [00781405432]

Lansoprazole, Amoxicillin and Clarithromycin KIT
Marketing CategoryANDA
Application NumberANDA202588
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-03-04

Drug Details

OpenFDA Data

SPL SET ID:62f096ec-8684-4c8c-a4c5-eb7c22f559c1
Manufacturer
RxNorm Concept Unique ID - RxCUI
  • 197517
  • 757968
  • 308191
  • 311277

    • NDC Crossover Matching brand name "Lansoprazole, Amoxicillin and Clarithromycin" or generic name "Lansoprazole, Amoxicillin And Clarithromycin"

    NDCBrand NameGeneric Name
    0781-4054Lansoprazole, Amoxicillin and ClarithromycinLansoprazole, Amoxicillin and Clarithromycin
    66993-418lansoprazole, amoxicillin and clarithromycinlansoprazole, amoxicillin and clarithromycin
    64764-702PREVPAClansoprazole, amoxicillin and clarithromycin
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.